Clinical Trial Update: Trial to Compare the Safety, Tolerability and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Influenza Virus in Children With Asthma [Phase 3]

View source ↗

Summary

A phase 3 trial comparing CAIV-T (live attenuated influenza vaccine) with an influenza vaccine in children with asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• CAIV-T (live attenuated influenza vaccine)
• Influenza vaccine (influenza vaccine)

Snippet

Sponsor: MedImmune LLC | Conditions: Asthma | Phase 3 | Status: COMPLETED